About Nxera Pharma
Nxera Pharma is a company based in Tokyo (Japan) founded in 1990. It operates as a HealthTech. The company has 374 employees as of December 31, 2024. Nxera Pharma offers products and services including HTL0039732. Nxera Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Aclaris Therapeutics, Neurocrine and PTC Therapeutics, among others.
- Headquarter Tokyo, Japan
- Employees 374 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nxera Pharma Co., Ltd.
-
Annual Revenue
$183.74 M (USD)125.87as on Dec 31, 2024
-
Net Profit
$-30.84 M (USD)32.74as on Dec 31, 2024
-
EBITDA
$-8.79 M (USD)79.03as on Dec 31, 2024
-
Latest Funding Round
$53.11 M (USD), Post-IPO
Nov 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
374
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Nxera Pharma
Nxera Pharma is a publicly listed company on the TSE with ticker symbol 4565 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Nxera Pharma
Nxera Pharma offers a comprehensive portfolio of products and services, including HTL0039732. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational treatment developed for cancer immunotherapy in trials.
Unlock access to complete
Leadership Team
22 people
Senior Team
14 people
Lead Team
12 people
Software Development Team
6 people
Legal and Compliance
3 people
Human Resources and Administration
3 people
Procurement Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of Nxera Pharma
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $53.1M
-
First Round
First Round
(01 Sep 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Post-IPO - Nxera Pharma | Valuation |
investors |
|
| Sep, 2021 | Amount | Grant - Nxera Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nxera Pharma
Nxera Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and OPF1 fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nxera Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nxera Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nxera Pharma Comparisons
Competitors of Nxera Pharma
Nxera Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Aclaris Therapeutics, Neurocrine and PTC Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nxera Pharma
Frequently Asked Questions about Nxera Pharma
When was Nxera Pharma founded?
Nxera Pharma was founded in 1990 and raised its 1st funding round 31 years after it was founded.
Where is Nxera Pharma located?
Nxera Pharma is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
How many employees does Nxera Pharma have?
As of Dec 31, 2024, the latest employee count at Nxera Pharma is 374.
What is the annual revenue of Nxera Pharma?
Annual revenue of Nxera Pharma is $183.74M as on Dec 31, 2024.
What does Nxera Pharma do?
Nxera Pharma is engaged in the development of innovative medicines aimed at transforming lives. The company is involved in the healthcare sector, specifically in pharmaceuticals and biotechnology. Emphasis is placed on accelerating drug development through investment in science and technology. Solutions are pursued to achieve breakthroughs in treatment, particularly in areas like cancer immunotherapy. Structure-based drug design is revolutionized by embracing advanced technology. Partnerships are sought to drive once-in-a-generation discoveries for patients in need.
Who are the top competitors of Nxera Pharma?
Nxera Pharma's top competitors include Jazz Pharmaceuticals, ADMA Biologics and PTC Therapeutics.
What products or services does Nxera Pharma offer?
Nxera Pharma offers HTL0039732.
Is Nxera Pharma publicly traded?
Yes, Nxera Pharma is publicly traded on TSE under the ticker symbol 4565.
Who are Nxera Pharma's investors?
Nxera Pharma has 2 investors. Key investors include European Union, and OPF1 fund.
What is Nxera Pharma's ticker symbol?
The ticker symbol of Nxera Pharma is 4565 on TSE.